Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines
Clinical trial NCT02493946 · COMPLETED
Trial details
- NCT number
- NCT02493946
- Sponsor
- Ipsen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2015-10-01
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.